Mass Tort Finance

Portfolio-level capital against MDL settlement curves.

We fund mass tort litigation at scale — MDL portfolios, bellwether cases, common benefit work, and post-settlement disbursement bridges. Underwritten using settlement curve models trained on historical MDL outcomes.

Capital sized to the docket, not to a single case. Pricing reflects the modeled aggregate recovery, not a blanket rate.

How We Fund Mass Tort
MDL Portfolio Funding
Capital against a tranche of MDL claimants. Funding sized to the modeled settlement curve — not a fixed loan amount. Draw as expenses incur, repay as bellwether verdicts and settlements land.
Bellwether Strategy Capital
Pre-trial capital for bellwether cases that set settlement value for the broader docket. The cases that most need capital are often the ones that define the litigation.
Common Benefit Fund
Capital for plaintiffs' steering committee common benefit work. MDL leadership counsel incur costs that are not reimbursed until the litigation resolves — we bridge that gap.
Settlement Disbursement Advances
Bridge capital between a global settlement agreement and individual claimant disbursement. Resolves the administrative lag that leaves resolved claimants waiting for payment.
How We Model Mass Tort

Mass tort underwriting requires modeling aggregate recovery — not individual case outcomes. Our models use historical MDL settlement data, bellwether verdict patterns, and claimant injury profiles to construct a settlement curve for each funded docket.

Funding is sized against the modeled expected value of the tranche, with capital deployment structured to match the litigation timeline — not a fixed draw schedule that assumes the docket resolves on a commercial loan timetable.

MDL Types We Fund
Pharmaceutical product liability (MDL)
Medical device defects (MDL)
Toxic exposure — PFAS, asbestos, benzene
Opioid litigation
Consumer product safety MDLs
Social media harm class/mass actions
Environmental mass tort
Aviation and transportation MDLs
How We Underwrite

Every capital decision at Criterica Capital is underwritten against outcomes, not collateral. Our models are trained on 106M+ real court records across US federal courts, state courts, and international jurisdictions.

We assess jurisdiction-level recovery rates, case-type outcome distributions, time-to-resolution curves, and attorney performance history before committing capital. No collateral. No credit check. Outcomes only.

01
Outcome models
23,500+ predictive models across case types and jurisdictions
02
Court record depth
106M+ verified decisions used in model training
03
Jurisdiction calibration
Circuit, district, and state-level recovery benchmarks
04
Recovery modeling
Expected value, settlement range, and duration estimates per case
Discuss mass tort portfolio funding.
Contact Our Team